Advertisement

Gangliosides of CSF and Plasma: Their Relation to the Nervous System

  • R. W. Ledeen
  • R. K. Yu
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 19)

Abstract

The lipid composition of body fluids has become a subject of growing interest in the field of sphingolipidoses and related disorders ever since the recognition that lipid abnormalities which characterize these diseases are often manifested in one or more such fluids. CSF1 has special significance in relation to neurological disorders and some evidence suggests that lipid alterations in this fluid may be correlated with certain categories of disease. Thus, on the basis of one survey Christensen and Matzke (1965) suggested that the ratio of cerebroside to lecithin provides an index of white matter destruction. A detailed study of CSF lipids in multiple sclerosis patients by Tourtel lotte and Haerer (1969) revealed several lipids to be elevated above normal with cerebrosides showing the most characteristic increase. Hagberg and Svennerholm (1960) detected sulfatides in the CSF of patients with late infantile metachromatic leucodystrophy but did not quantify or compare them with normal levels.

Keywords

Sialic Acid Bovine Plasma Brain Ganglioside Total Sialic Acid Cerebellar Astrocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernheimer, H. (1968). Klin. Wschr.46, 258.Google Scholar
  2. Bernheimer, H. (1969). Klin. Wschr. Li, 227.Google Scholar
  3. Brunngraber, E. (1969). In Handbook of Neurochemistry (A. Lajtha, ed. ), Plenum (New York), p. 223.Google Scholar
  4. Christensen, L., and Matzke, J. (1965). Acta Neurol. Scand.41, 445.Google Scholar
  5. Folch, J., Lees, M., and Sloane-Stanley, G. (1957). J. Biol. Chem. 226, 497.Google Scholar
  6. Hagberg, B., and Svennerholm, L. (1960), Acta Paediat. Scand.4a, 690.Google Scholar
  7. Ledeen, R., Salsman, K., and Cabrera, M. (1968a). J. Lipid Res. 2, 129.Google Scholar
  8. Ledeen, R., Salsman, K., and Cabrera, M. (1968b). Biochemistry j, 2287.Google Scholar
  9. Marcus, D., and Cass, L. (1969). Science164, 553.Google Scholar
  10. Nagai, Y., and Kanfer, J. (1971). J. Lipid Res.12, 143.Google Scholar
  11. Sambasivarao, K., and McCluer, R. (1964). J. Lipid Res.2, 103.Google Scholar
  12. Sastry, P., and Stancer, H. (1968a). Clin. Chim. Acta20, 487.Google Scholar
  13. Sastry, P., and Stancer, H. (1968b). Clin. Chim. Acta22, 301.Google Scholar
  14. Suzuki, K. (1967). In Inborn Disorders of Sphingolipid Metabolism (S.M. Aronson and B.W. Volk, eds. ), Pergamon Press, p. 215.Google Scholar
  15. Sweeley, C., and Moscatelli, E. (1959). J. Lipid Res.1, 40.Google Scholar
  16. Tourtellotte, W. (1959). Neurol.2, 375.Google Scholar
  17. Tourtellotte, W., and Haerer, A. (1969). Arch. Neurol.20, 605.Google Scholar
  18. Vance, D., and Sweeley, C. (1967). J. Lipid Res.8, 621.Google Scholar
  19. Weller, R., and Wisniewski, H. (1965). Brain 22, 819.Google Scholar
  20. Yu, R., and Ledeen, R. (1970). J. Lipid Res.11, 506.Google Scholar
  21. Yu, R., and Ledeen, R. (1971). In Preparation.Google Scholar

Copyright information

© Springer Science+Business Media New York 1972

Authors and Affiliations

  • R. W. Ledeen
    • 1
  • R. K. Yu
    • 1
  1. 1.Saul R. Korey Department of Neurology and Department of BiochemistryAlbert Einstein College of MedicineBronxUSA

Personalised recommendations